Antivert and Rebif drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Antivert (meclizine hydrochloride) and Rebif (interferon beta-1a). Common drug interactions include intervertebral disc protrusion among females and abasia among males.

The phase IV clinical study analyzes what interactions people have when they take Antivert and Rebif. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Rebif?

Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. eHealthMe is studying from 61,126 Rebif users. Check the latest studies of Rebif.

On Jul, 13, 2026

44 people who take Antivert and Rebif together, and have interactions are studied.

What are the common drug interactions of Antivert and Rebif, by gender? *:

female:

Intervertebral disc protrusion (spinal disc protrusion)
Kidney infection
Malignant melanoma (skin cancer rises from melancytes)
Migraine (headache)
Mobility decreased (ability to move is reduced)
Mood swings (an extreme or rapid change in mood)
Muscle spasms (muscle contraction)
Mydriasis (a dilation of the pupil)
Nasopharyngitis (inflammation of the nasopharynx)
Nerve compression

male:

Abasia (inability to walk)
Activities of daily living impaired
Drug hypersensitivity
Dysarthria (speech disorder)
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
Fall
Head injury
Hyperaesthesia
Hyperthyroidism (over activity of the thyroid gland)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the common drug interactions of Antivert and Rebif, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Loss of consciousness

30-39:

Coeliac disease (simple food intolerance)
Diarrhoea
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
Hepatic enzyme increased
Hyperthyroidism (over activity of the thyroid gland)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Malaise (a feeling of general discomfort or uneasiness)
Malignant melanoma (skin cancer rises from melancytes)
Muscle spasms (muscle contraction)
Optic neuritis (optic nerve inflammation)

40-49:

Influenza like illness
Injection site reaction
Osteonecrosis (death of bone)
Renal cancer (cancer of kidney)
Blood glucose increased
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Hyperaesthesia
Staphylococcal infection (an infection with staphylococcus bacteria)
Stress

50-59:

Asthenia (weakness)
Chills (felling of cold)
Decreased appetite
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Gallbladder disorder
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Injection site erythema (redness at injection site)
Injection site haematoma (localized swelling filled with blood at injection site)

60+:

Breast cancer
Staphylococcal infection (an infection with staphylococcus bacteria)
Sepsis (a severe blood infection that can lead to organ failure and death)
Abdominal pain
Abdominal pain upper
Anxiety
Catheter related infection
Chest discomfort
Dysstasia (difficulty in standing)
Injection site erythema (redness at injection site)

What are the existing conditions these people have? *

Stress And Anxiety: 7 people, 15.91%
Depression: 7 people, 15.91%
Sleep Disorder: 6 people, 13.64%
Neuralgia (pain in one or more nerves): 6 people, 13.64%
Nausea (feeling of having an urge to vomit): 6 people, 13.64%
Thyroid Diseases: 6 people, 13.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 13.64%
Constipation: 5 people, 11.36%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 11.36%
Pain: 4 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and Rebif?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously